The top after-market NASDAQ Stock Market gainers are: Herman Miller, Intevac, Magic Software Enterprises, BioCryst Pharmaceuticals, and Pharmasset. The top after-market NASDAQ Stock Market losers are: First Pactrust Bancorp, WD-40, CEVA, Insulet, Saba Software, Apple, and Google.

Gainers

Herman Miller Inc. (MLHR) stock grew 6.54 percent to $25.57 in the after-market trading. Profit for the fourth quarter was $17.1 million or $0.30 per share, up from $2.1 million or breakeven per share last year. Adjusted earnings rose to $0.30 per share from $0.10 per share. Sales grew 37.3 percent to $441.5 million. Analysts had expected profit of $0.25 per share on revenue of $417.98 million. We continue to be encouraged by the growth of our business, which for the past several quarters has exceeded that of the broader industry in North America. Importantly, our results this quarter reflect a substantial improvement in operating leverage, said Greg Bylsma, chief financial officer of Herman Miller.

Intevac Inc. (IVAC) stock gained 5.24 percent to $10.40 in the after-market trading.

Magic Software Enterprises Ltd. (MGIC) stock increased 5.13 percent to $5.12 in the after-market trading.

BioCryst Pharmaceuticals, Inc. (BCRX) stock gained 4.84 percent to $4.01 in the after-market trading.

Pharmasset, Inc. (VRUS) stock increased 4.38 percent to $110.18 in the after-market trading. The company said the United States Patent and Trademark Office has issued U.S. patent 7,964,580 titled Nucleoside Phosphoramidate Prodrugs. This patent generally relates to the composition of matter of PSI-7977 and its diastereomeric mixture for the treatment of hepatitis C virus (HCV). PSI-7977, a uracil nucleotide analogue polymerase inhibitor of HCV, is being studied in multiple phase 2 trials.

Today's announcement is a credit to our in-house research team in discovering new HCV product candidates. As the '580 patent is not due to expire until 2029, not including any patent term extension, it should become an important part of a growing portfolio of issued patents covering PSI-7977, said Schaefer Price, Pharmasset's President and Chief Executive Officer.

Losers

First Pactrust Bancorp Inc. (FPTB) stock fell 7.07 percent to $15.12 in the after-market trading. The company said it has commenced an underwritten public offering of 1,583,641 shares of its voting common stock. Robert W. Baird & Co. Incorporated is serving as the sole book-running manager of the underwritten public offering, and D.A. Davidson & Co., FIG Partners, LLC and Wunderlich Securities, Inc. are serving as co-managers of that offering. The company plans to grant the underwriters a 30-day option to purchase up to an additional 237,546 shares sold in the underwritten public offering to cover over-allotments, if any.

Additionally, pursuant to existing contractual rights and subject to completion of the underwritten public offering, St. Cloud Capital Partners II, L.P. and TCW Shared Opportunities Fund V, L.P., each an existing shareholder of the company, have agreed to purchase from the company in a separate registered offering made directly to them by the company, an aggregate of 207,360 shares of the company’s voting common stock. If and to the extent the underwriters exercise their over-allotment option, the Existing Investors have agreed to purchase from the company an aggregate of up to 31,104 additional shares of its voting common stock, with the percentage of such additional shares to be purchased by them equal to the same percentage of the over-allotment option exercised by the underwriters.

The company intends to use the net proceeds from the offerings for general corporate purposes, which may include, among other things, investments at the holding company level, capital infusions to support the growth of Pacific Trust Bank, acquisitions or other business combinations and other business opportunities.

WD-40 Co. (WDFC) stock tumbled 6.50 percent to $38.55 in the after-market trading. The company said it lowered its fiscal 2011 earnings guidance to range of $2.05 to $2.15 per share from previous forecast of $2.23 to $2.35 per share. The company also reduced its 2011 sales outlook to range of $330 million to $340 million, or growth of 2.6 percent to 5.7 percent, from previous range of $335 million to $350 million. Street predicts profit of $2.27 per share on revenue of $340.69 million. Gross margin for the full year is expected to be close to 50.0 percent. The company projects advertising and promotion expenses to be close to 7.5 percent of net sales.

CEVA Inc. (CEVA) stock slid 6.35 percent to $27.96 in the after-market trading.

Insulet Corp. (PODD) stock declined 6.05 percent to $19.25 in the after-market trading. The company said it plans to offer $110 million principal amount of convertible senior notes due 2016 pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission on Wednesday. The company also plans to grant the underwriters an option to purchase up to an additional $16.5 million principal amount of notes to cover over-allotments, if any.

Concurrent with the notes offering, the company's stockholders, who received 1,197,631 shares of the Company's common stock in connection with the previously announced acquisition of Neighborhood Diabetes, intend to offer 1,153,420 of the Shares pursuant to an effective shelf registration statement filed with the SEC on June 7 and a prospectus supplement filed with the SEC Wednesday. The completion of the common stock offering is not contingent upon the completion of the notes offering and the completion of the notes offering is not contingent upon the completion of the common stock offering.

Insulet intends to use the net proceeds from the notes offering for general corporate purposes, including the possible repurchase of existing debt securities, which mature in June 2013. J.P. Morgan Securities LLC is acting as the sole book-running manager for the notes offering. J.P. Morgan Securities LLC is acting as sole book-running manager and Canaccord Genuity Inc. is acting as lead manager for the common stock offering.

Saba Software, Inc. (SABA) stock decreased 3.70 percent to $8.33 in the after-market trading.

Apple Inc. (AAPL) stock moved down 0.35 percent to $321.48 in the after-market trading. Apple may face hurdles in stopping Amazon.com Inc. (AMZN) from using Apple's App Store name through a trademark lawsuit, according to a Reuters report. Apple filed a lawsuit saying that Amazon has improperly used Apple's App Store name to solicit software throughout the United States.

At the hearing in an Oakland federal court on Wednesday, U.S. District Judge Phyllis Hamilton said she would reread some of the supporting papers in the case, Reuters reported citing a persion who was at the hearing. However, Hamilton said Apple had a stumbling block in proving that anyone would confuse Apple's App Store for Amazon's Appstore for Android, the individual told Reuters. Hamilton did not make a final ruling at the hearing, court records show.

Google Inc. (GOOG) stock moved down 0.21 percent to $485.98 in the after-market trading. Google's reluctance to provide a top executive for testimony to a Senate panel probing its market power has prompted threats of subpoenas for Chief Executive Officer Larry Page and Chairman Eric Schmidt, according to a Bloomberg report. The Democratic chairman and leading Republican on the antitrust subcommittee asked Google to provide one of the company’s two senior executives before Congress’s August recess, according to copy of letter dated June 10 obtained by Bloomberg. The letter urged a resolution by agreement to avoid more formal procedures.

The threat of subpoenas is one of the ways the committee is pressuring Google to send Page or Schmidt, Bloomberg reported citing people familiar with negotiations between the panel and the company. The possibility of subpoenas was discussed with Google in connection with the letter. The letter asked Google to respond by June 15. Google has offered to have Chief Legal Officer David Drummond appear at the hearing, according to the letter.